Dummy Project
CARDIA-301
Enrollment failure may actually be protocol-design failure.
Project Story
What readers should notice
CARDIA-301 is written as a case a working PM can recognize, not as a sterile protocol summary. The project sits in Cardiovascular as a Randomized controlled study, but the real teaching point is this: a familiar Phase III trap: the recruitment curve looks like the problem, but the real fracture may sit in eligibility, visit burden, site mix, endpoint timing, and the assumptions leaders approved months earlier. When readers compare CARDIA-301 with their own project, they should look for the same pressure points: what the protocol assumes, what sites can actually do, what vendors must prove, what data must remain credible, what safety or ethics concern could change the plan, and what Daniel Liang's team would ask before accepting a green dashboard as truth.
Lifecycle Coverage
Book Mentions
How to read this case
Look for the moment when ordinary project language stops being enough: a date slips, an assumption fails, a vendor signal loses meaning, or a clinical concern changes the work. Then follow the chapter links, toolkit examples, glossary terms, and packet artifacts to compare this fictional pressure pattern with a real project you manage.